The Feasibility of Pertussis Immunization in a Canadian Emergency Department

University of Prince Edward Island

Status

Completed

Conditions

Pertussis

Treatments

Behavioral: Tdap

Study type

Interventional

Funder types

Other

Identifiers

NCT03304275

6007232

Details and patient eligibility

About

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency will be measured.

Full description

This study is a prospective randomized, controlled trial of two strategies to provide patients with the pertussis vaccine. Eligible adult patients with be offered pertussis vaccination in the Emergency Department vs. a referral to Public Health for pertussis vaccination. The effect of both strategies on triage time as well as measure of emergency department efficiency including length of stay, time to physician and left without being seen rates will be compared. At a four-month follow up, rates of pertussis vaccination will be measured.

Enrollment

644 patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Adults age 18 and above
Have not received Tdap vaccine as an adult (age 18 and above) or have not received Tdap vaccine within 10 years, or unsure of vaccination status

Exclusion criteria

Acute significant illness (Canadian Triage and Acuity Scale = 1)
Deemed "in too much distress" by triage nurse
Acute Febrile illness
Allergy to vaccine or vaccine components
Pts presenting for wound care (are normally given the vaccine as part of wound care)
Pregnancy < 26 weeks